Highlights
NYSE: NVO       Novo Nordisk A/S
Last Price Today's Change   Day's Range   Trading Volume
66.33   0.00 (0.00%)  0.00 - 0.00  0

Overview

 
Avg Volume (4 weeks):1,043,900
4 Weeks Range:66.12 - 73.81
4 Weeks Price Volatility (%):
89.87%
52 Weeks Range:49.24 - 73.81
52 Weeks Price Volatility (%):
89.87%
Average Price Target: 193.60
Price Target Upside/Downside: +127.27

Headlines



No recent Headlines for this stock.


Business Background

Novo Nordisk A/S is a global healthcare company engaged in diabetes care. The Company is also engaged in the discovery, development, manufacturing and marketing of pharmaceutical products. The Company operates through two business segments: diabetes and obesity care, and biopharmaceuticals. The Company's diabetes and obesity care segment covers insulin, GLP-1, other protein-related products, such as glucagon, protein-related delivery systems and needles, and oral anti-diabetic drugs. The Company's biopharmaceuticals segment covers the therapy areas of hemophilia care, growth hormone therapy and hormone replacement therapy. The Company also offers Saxenda product to treat obesity. It offers a range of products, including NovoLog/NovoRapid; NovoLog Mix/NovoMix; Prandin/NovoNorm; NovoSeven; Norditropin, and Vagifem. As of December 31, 2016, it marketed its products in over 180 countries. Its regional structure consists of two commercial units: North America and International Operations.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

9261 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 KSMT 9.5930.00 
 HIPS 11.490.00 
 HONE 9.420.00 
 ENZL 60.480.00 
 KOD 99.760.00 
 UPRO 52.850.00 
 COLD 36.140.00 
 ALYA 2.430.00 
 CIGI 71.850.00 
 AXNX 48.870.00